Rise Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $98K | Sell |
242
-13
| -5% | -$5.27K | 0.04% | 153 |
|
|
2025
Q1 | $127K | Buy |
255
+4
| +2% | +$1.99K | 0.06% | 123 |
|
|
2024
Q4 | $130K | Sell |
251
-5
| -2% | -$2.6K | 0.06% | 121 |
|
|
2024
Q3 | $159K | Buy |
256
+2
| +0.8% | +$1.24K | 0.08% | 111 |
|
|
2024
Q2 | $141K | Sell |
254
-102
| -29% | -$56.5K | 0.07% | 116 |
|
|
2024
Q1 | $207K | Buy |
356
+206
| +137% | +$120K | 0.11% | 89 |
|
|
2023
Q4 | $79.8K | Hold |
150
| – | – | 0.06% | 119 |
|
|
2023
Q3 | $76.1K | Buy |
150
+43
| +40% | +$21.8K | 0.06% | 106 |
|
|
2023
Q2 | $55.9K | Sell |
107
-3
| -3% | -$1.57K | 0.04% | 136 |
|
|
2023
Q1 | $63.5K | Buy |
110
+1
| +0.9% | +$577 | 0.05% | 139 |
|
|
2022
Q4 | $60.1K | Hold |
109
| – | – | 0.05% | 139 |
|
|
2022
Q3 | $55K | Buy |
109
+100
| +1,111% | +$50.5K | 0.05% | 141 |
|
|
2022
Q2 | $5K | Sell |
9
-6
| -40% | -$3.33K | 0.01% | 451 |
|
|
2022
Q1 | $9K | Hold |
15
| – | – | 0.01% | 352 |
|
|
2021
Q4 | $10K | Buy |
+15
| New | +$10K | 0.01% | 326 |
|